Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/178573
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Pham, ThanhTruc | es_ES |
dc.contributor.author | Walden, Madeline | es_ES |
dc.contributor.author | Butler, Christopher | es_ES |
dc.contributor.author | Díaz-González, Rosario | es_ES |
dc.contributor.author | Pérez-Moreno, Guiomar | es_ES |
dc.contributor.author | Ceballos-Pérez, Gloria | es_ES |
dc.contributor.author | Gómez-Pérez, Veronica | es_ES |
dc.contributor.author | García-Hernández, Raquel | es_ES |
dc.contributor.author | Zecca, Henry | es_ES |
dc.contributor.author | Krakoff, Emma | es_ES |
dc.contributor.author | Kopec, Brian | es_ES |
dc.contributor.author | Ichire, Ogar | es_ES |
dc.contributor.author | Mackenzie, Caden | es_ES |
dc.contributor.author | Pitot, Marika | es_ES |
dc.contributor.author | Ruiz-Pérez, Luis Miguel | es_ES |
dc.contributor.author | Gamarro, Francisco | es_ES |
dc.contributor.author | González-Pacanowska, Dolores | es_ES |
dc.contributor.author | Navarro, M. | es_ES |
dc.contributor.author | Dounay, Amy B. | es_ES |
dc.date.accessioned | 2019-03-26T12:30:04Z | - |
dc.date.available | 2019-03-26T12:30:04Z | - |
dc.date.issued | 2017-08-15 | - |
dc.identifier.citation | Bioorganic and Medicinal Chemistry Letters | es_ES |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | http://hdl.handle.net/10261/178573 | - |
dc.description.abstract | In 2014, a published report of the high-throughput screen of>42,000 kinase inhibitors from GlaxoSmithKline against T. brucei identified 797 potent and selective hits. From this rich data set, we selected NEU-0001101 (1) for hit-to-lead optimization. Through our preliminary compound synthesis and SAR studies, we have confirmed the previously reported activity of 1 in a T. brucei cell proliferation assay and have identified alternative groups to replace the pyridyl ring in 1. Pyrazole 24 achieves improvements in both potency and lipophilicity relative to 1, while also showing good in vitro metabolic stability. The SAR developed on 24 provides new directions for further optimization of this novel scaffold for anti-trypanosomal drug discovery. | es_ES |
dc.description.sponsorship | Boettcher Foundation's Webb-Waring Biomedical Research Program; Boettcher Collaboration Grant; Research Corporation Cottrell College Science Award; National Institute of Allergy and Infectious Diseases (US):R01AI114685; Ministerio de Economia, Industria y Competitividad (España) SAF2015-71444-P; SAF2015-68042-R; SAF2016-79957-R; Junta de Andalucia CTS-7282; Subdireccion General de Redes y Centros de Investigacion Cooperativa (RICET) RD16/0027/0019, DG-P RD16/0027/0014; NSF-MRI CHE-1429567 | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.relation | info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2016-79957-R | - |
dc.relation | info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2015-68042-R | - |
dc.relation | info:eu-repo/grantAgreement/MINECO/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2015-71444-P | - |
dc.rights | closedAccess | es_ES |
dc.subject | Trypanosomiasis | es_ES |
dc.subject | HAT | es_ES |
dc.subject | Trypanosoma brucei | es_ES |
dc.subject | Quinazolinone | es_ES |
dc.subject | Hit-to-lead | es_ES |
dc.title | Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei | es_ES |
dc.type | artículo | es_ES |
dc.identifier.doi | 10.1016/j.bmcl.2017.07.032 | - |
dc.description.peerreviewed | Peer reviewed | es_ES |
dc.relation.publisherversion | https://www.ncbi.nlm.nih.gov/pubmed/28729055 | es_ES |
dc.identifier.e-issn | 1464-3405 | - |
dc.contributor.funder | Ministerio de Economía, Industria y Competitividad (España) | es_ES |
dc.contributor.funder | Ministerio de Economía, Industria y Competitividad (España) | es_ES |
dc.contributor.funder | Ministerio de Economía, Industria y Competitividad (España) | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.relation.csic | Sí | es_ES |
oprm.item.hasRevision | no ko 0 false | * |
dc.identifier.funder | http://dx.doi.org/10.13039/501100004587 | es_ES |
dc.identifier.funder | http://dx.doi.org/10.13039/501100010198 | es_ES |
dc.identifier.pmid | 28729055 | - |
dc.type.coar | http://purl.org/coar/resource_type/c_6501 | es_ES |
item.openairetype | artículo | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.languageiso639-1 | en | - |
Aparece en las colecciones: | (IPBLN) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,35 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
2
checked on 11-abr-2024
SCOPUSTM
Citations
6
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
6
checked on 26-feb-2024
Page view(s)
225
checked on 19-abr-2024
Download(s)
29
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.